The Palliative Effect of Endobronchial Brachytherapy for Previously Irradiated Patients with Lung Cancer
![]() |
Park, Young-Je
(Departments of Radiation Oncology, College of Medicine, Korea University)
Kim, Kwang-Taik (Departments of Thoracic Surgery, College of Medicine, Korea University) Yang, Dae-Sik (Departments of Radiation Oncology, College of Medicine, Korea University) Lee, Suk (Departments of Radiation Oncology, College of Medicine, Korea University) Kim, Chul-Yang (Departments of Radiation Oncology, College of Medicine, Korea University) |
1 | Freitag L, Ernst A, Thomas M, Prenzel R, Wahlers B, Macha HN. Sequential photodynamic therapy (PDT) and high dose brachytherapy for endobronchial tumour control in patients with limited bronchogenic carcinoma. Thorax 2004;59:790-793 DOI ScienceOn |
2 | Huber RM, Fischer R, Hautmann H, Pollinger B, Haussinger K, Wendt T. Does additional brachytherapy improve the effect of external irradiation? A prospective, randomized study in central lung tumors. Int J Radiat Oncol Biol Phys 1997; 38:533-540 DOI ScienceOn |
3 | Taulelle M, Chauvet B, Vincent P, et al. High dose rate endobronchial brachytherapy: results and complications in 189 patients. Eur Resp J 1998;11:162-168 DOI |
4 | Gollins SW, Ryder WDJ, Burt PA, Barber PV, Stout R. Massive hemoptysis death and other morbidity associated with high dose rate intraluminal radiotherapy for carcinoma of the bronchus. Radiother Oncol 1996;39:105-116 DOI ScienceOn |
5 | Kelly JF, Delclos ME, Morice RC, Huaringa A, Allen PK, Komaki R. High-dose-rate endobronchial brachytherapy effectively palliates symptoms due to airway tumors: The 10-year M. D. Anderson Cancer Center experience. Int J Radiat Oncol Biol Phys 2000;48:697-702 DOI ScienceOn |
6 | Gollins SW, Burt PA, Barber PV, Stout R. High dose rate intraluminal radiotherapy for carcinoma of the bronchus: outcome of treatment of 406 patients. Radiother Oncol 1994;33: 31-40 DOI ScienceOn |
7 | Hennequin C, Bleichner O, Tredaniel J, et al. Long-term results of endobronchial brachytherapy: a curative treatment? Int J Radiat Oncol Biol Phys 2007;67:425-430 |
8 | Ofiara L, Roman T, Schwartzman K, Levy RD. Local determinants of response to endobronchial high-dose rate brachytherapy in bronchogenic carcinoma. Chest 1997;112:946-953 DOI ScienceOn |
9 | Boxem T, Muller M, Venmans B, Postmus P, Sutedja T. Nd-YAG laser vs bronchoscopic electrocautery for palliation of symptomatic airway obstruction: A cost-effectiveness study. Chest 1999;116:1108-1112 DOI ScienceOn |
10 | Langendijk H, Jong JD, Tjwa M, et al. External irradiation versus external irradiation plus endobronchial brachytherapy in inoperable non-small cell lung cancer: a prospective randomized study. Radiother Oncol 2001;58:257-268 DOI ScienceOn |
11 | Vergnon JM, Huber RM, Moghissi K. Place of cryotherapy, brachytherapy and photodynamic therapy in therapeutic bronchoscopy of lung cancers. Eur Respir J 2006;28:200-218 DOI ScienceOn |
12 | Sheski FD, Mathur PN. Cryotherapy, electrocautery, and brachytherapy. Clin Chest Med 1999;20:123-138 DOI |
13 | Stout R, Barber P, Burt P, et al. Clinical and quality of life outcomes in the first United Kingdom randomized trial of endobronchial brachytherapy (intraluminal radiotherapy) vs. external beam radiotherapy in the palliative treatment of inoperable non-small cell lung cancer. Radiother Oncol 2000;56:323-327 DOI ScienceOn |
14 | Wu KL, Jiang GL, Qian H, et al. Three-dimensional conformal radiotherapy for locoregionally recurrent lung carcinoma after external beam irradiation: a prospective phase I-II clinical trial. Int J Radiat Oncol Biol Phys 2003;57:1345-1350 DOI ScienceOn |
15 | Ahn YC, Lim DH, Choi DR, et al. Short-term results of endobronchial brachytherapy for malignant airway obstructions. J Korean Soc Ther Radiol Oncol 1996;14:299-306 |
16 | Langendijk JA, Tjwa M, Jong JD, Velde GT, Wouters E. Massive hemoptysis after radiotherapy in inoperable non-small cell lung carcinoma: is endobronchial brachytherapy really a risk factor? Radiother Oncol 1998;49:175-183 DOI ScienceOn |
17 | Hara R, Itami J, Aruga T, et al. Risk factors for massive hemoptysis after endobronchial brachytherapy in patients with tracheobronchial malignancies. Cancer 2001;92:2623-2627 DOI ScienceOn |
18 | Ung YC, Yu E, Falkson C, Haynes AE, Stys-Norman D, Evans WK. The role of high-dose-rate brachytherapy in the palliation of symptoms in patients with non-small-cell lung cancer: A systemic review. Brachytherapy 2006;5:189-202 DOI ScienceOn |
19 | The Criteria Committee of the New York Heart Association. Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels. 9th ed. Boston, Mass: Little, Brown & Co. 1994:253-256 |
20 | Cavaliere S, Venuta F, Foccoli P, Toninelli C, La Face B. Endoscopic treatment of malignant airway obstructions in 2,008 patients. Chest 1996;110:1536-1542 DOI ScienceOn |
21 | Tada T, Fukuda H, Matsui K, et al. Non-small-cell lung cancer: reirradiation for loco-regional relapse previously treated with radiation therapy. Int J Clin Oncol 2005;10:247-250 DOI |
![]() |